Halozyme Reports Impressive Financial Growth and Raises Guidance for 2025 Halozyme Therapeutics shares quarterly results showing significant revenue growth, raising 2025 guidance with remarkable achievements in drug delivery technology.

Halozyme Reports Impressive Financial Growth and Raises Guidance for 2025 #United_States #San_Diego #Halozyme #ENHANZE #Elektrofi

Acquisitions: #31C > #Xynthor; #Carta > #Accelex; #Credo > #Hyperlume; #Databrick > #Mooncake; #EnteroTherapeutics > #GRIDAI; #Halozyme > #Elektrofi; #Harness > #QwietAI; #HoneyBook > #Fine.dev; #Insight > #Inspire11; #Karbon > #Aider; #Lightcast > #Simply